Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Aarhus Universitet Forside
Hjælp og OSS
English
Dansk
Forside
Profiler
Forskningsenheder
Projekter
Publikation
Priser
Aktiviteter
Kurser
Presse/medier
Søg efter ekspertise, navn eller tilknytning
May Murra
Ph.d.-studerende
,
Institut for Biomedicin - Forskning og uddannelse, Skou-bygningen
E-mail
au207101
biomed.au
dk
Høegh-Guldbergs Gade 10
,
1115
8000
Aarhus C
Danmark
2018
2025
Publikationer pr. år
Vis
Fingeraftryk
Netværk
Publikation
(9)
Lignende profiler
(6)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor May Murra er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Medicine and Dentistry
Streptococcus Agalactiae
100%
Infection
91%
Neonatal Infant
87%
COVID-19
87%
Newborn Infection
87%
Sepsis
87%
Cohort Analysis
87%
Meningitis
84%
Severe Acute Respiratory Syndrome Coronavirus 2
70%
Symptom
56%
Nasopharyngeal Swab
35%
Polymerase Chain Reaction
35%
Cerebrospinal Fluid
31%
Cord Blood
17%
Household
17%
Prevalence
17%
Self-Diagnosis
17%
Childbirth
17%
Mixed Model
12%
Linear Regression Analysis
12%
Public Health
12%
Bacterial Infection
12%
Escherichia coli
12%
Treatment Duration
9%
Assisted Ventilation
9%
Infant Care
9%
Cardiovascular System
9%
Onset Age
9%
Disease Severity
9%
Neurologic Disease
9%
Apgar Score
9%
Group B Streptococcal Infection
9%
Disseminated Intravascular Coagulation
9%
Gestational Age
9%
Serotype
9%
Assisted Circulation
9%
Multilocus Sequence Typing
9%
Streptococcus Vaccine
9%
Pediatrician
9%
Keyphrases
Early-onset Neonatal Infection
87%
Routine Vaccination
87%
Vaccination in Pregnancy
87%
School Performance
87%
Meningitis
87%
National Cohort Study
87%
Standard Deviation Score
72%
Sepsis
58%
SARS-CoV-2 PCR
43%
Culture-positive Sepsis
29%
COVID-19 Infection
21%
Pre-vaccine
21%
Household Contacts
21%
Societal Lockdown
21%
Rectal Swab
21%
SARS-CoV-2 Infection
21%
Seropositive Mothers
21%
Cautious Behavior
21%
Mixed Models
14%
Child Performance
14%
Public Health Level
14%
Invasive Bacterial Infection
14%
Point Estimate
14%
Early Infection
14%
Substantial Reduction
14%
First Week of Life
14%
Escherichia Coli
14%
Group B Streptococcus
14%
Performance-based
14%
Large Reduction
14%
Early Onset
14%
Match Analysis
14%
Nationwide Registers
14%
Linear Regression
14%
Cerebrospinal Fluid
14%
Late-onset Sepsis
14%
Public Schools
14%
Blood Fluid
14%
Singleton
14%
Register Study
14%
Multivariable
14%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
87%
Monospecific Antibody
87%
Aggregatibacter
87%
Placental Transfer
87%
Streptococcus Agalactiae
87%
Whole Genome Sequencing
87%
Polymerase Chain Reaction
50%
Immunoglobulin G Antibody
37%
Umbilical Cord
25%
Cerebrospinal Fluid
17%
Type Strain
14%
Aggregatibacter Aphrophilus
14%
Computer Model
14%
Phylogeny
14%
DNA Hybridization
14%
Gene Sequence
14%
Surface Property
14%
COVID-19
12%
Medical Record
12%
Immunoglobulin M
12%
Severe Acute Respiratory Syndrome
12%
Serum (Blood)
12%
Enzyme-Linked Immunosorbent Assay
12%
Venous Blood
12%
Cord Serum
12%
Meningitis
8%
Vaccine Efficacy
8%
Potential Difference
8%
Serotype
8%
Streptococcus Vaccine
8%
Multilocus Sequence Typing
8%
Achilles Reflex
6%
